Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

Tetra Bio-Pharma Announces Change to its Board of Directors

Accesswire June 22, 2020

Tetra Bio-Pharma's Management Provides Regulatory Update of ARDS-003 for the Potential Prevention and Treatment of Cytokine Release Syndrome

Accesswire June 17, 2020

Tetra Bio-Pharma's Pleased to Announce Advancement of QIXLEEF(TM) and CAUMZ(TM) Clinical Trials Ahead of Annual General Meeting

Accesswire June 5, 2020

Tetra Bio-Pharma and Storz & Bickel Enter into Commercial Sales Agreement for the Mighty Medic Vaporizer

Accesswire June 4, 2020

Tetra Bio-Pharma and Altus Formulation Form New Company "TALLC" to Exploit TA-A001

Accesswire June 3, 2020

Tetra Bio-Pharma Provides HCC011 Program Update Following Type B Meeting with USA FDA

Accesswire June 2, 2020

The Top Cannabis Bullboards: March - May 2020

Stockhouse Editorial June 1, 2020

Tetra Bio-Pharma Announces Foreign Patent and Reinforces its Ophthalmic IP Portfolio with a New Australian Patent

Accesswire May 26, 2020

Tetra Bio-Pharma Announces Closing of Public Offering

Canada NewsWire May 22, 2020

Deux compagnies Québécoises unissent leurs forces afin de rendre disponible un masque haute performance pour nos Anges Gardiens

Accesswire May 15, 2020

IIROC Trading Resumption - TBP

Canada NewsWire May 15, 2020

Two Quebec Companies Joined Forces to Make Healthcare Mask for our "Guardian Angels"

Accesswire May 15, 2020

Tetra Bio-Pharma Announces Sizing of Public Offering

GlobeNewswire May 15, 2020

Tetra Bio-Pharma Announces Overnight Marketed Offering

GlobeNewswire May 14, 2020

IIROC Trading Halt - TBP

Canada NewsWire May 14, 2020

Tetra Announces Resignation of President

Accesswire May 13, 2020

Tetra Bio-Pharma Provides Update on PPP003 Inflammatory Cytokine Reduction Drug Program

Accesswire May 11, 2020

Tetra Bio-Pharma Obtains Health Canada Approval for Renewal of its Veterinary Clinical Study

Accesswire May 11, 2020

Tetra Bio-Pharma Engages energi PR as its Public Relations Firm

Accesswire May 8, 2020

Tetra Bio-Pharma Discusses Development of PPP003 Drug for Cytokine Reduction with The Stock Day Podcast

Newsfile May 7, 2020